usefulness of vitamin c in the reduction of blood pressure and fat levels in mild to moderate hypertensive patients.
Not Applicable
- Conditions
- Health Condition 1: I10-I16- Hypertensive diseases
- Registration Number
- CTRI/2021/09/036310
- Lead Sponsor
- Dr V DIVYA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients taking telmisartan for hypertension
2.Patients with mild to moderate hypertension
3.Patients willing to give written informed consent
Exclusion Criteria
1.Patient age <18 year and >65 years
2.Uncontrolled Hypertension
3.Previous history of malignancy
4.Previous history of myocardial infection
5.Current or potential pregnancy / Lactation
6.Chronic kidney disease
7.H/O psychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in blood pressureTimepoint: 0,20 weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1)Reduction in lipid levels <br/ ><br>2)Reduction in Atherogenic index of plasma <br/ ><br> <br/ ><br>Timepoint: 0,20 WEEKS